Resistance of SARS-CoV-2 variants to neutralization by convalescent plasma from early COVID-19 outbreak in Singapore. (2021)
Attributed to:
G2P-UK; A National Virology Consortium to address phenotypic consequences of SARSCoV-2 genomic variation
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41541-021-00389-2
PubMed Identifier: 34697298
Publication URI: http://europepmc.org/abstract/MED/34697298
Type: Journal Article/Review
Volume: 6
Parent Publication: NPJ vaccines
Issue: 1
ISSN: 2059-0105